Ushbu ish iqtibos qilgan ishlar
67 ta ish
Ish: Molecular dynamics insights into the redox effects on PD-1/PD-L1 and PD-1/PD-L2 interactions
The evolution of cancer surgery and future perspectives
Lynda Wyld, Riccardo A. Audisio, Graeme J. Poston
Sharh maqola20143 iqtibosABIPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Andreas D. Hartkopf, Florin‐Andrei Taran, Markus Wallwiener +4
Sharh maqola20163 iqtibosABIImmune Checkpoint Inhibitors in Cancer Therapy
Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani +6
Sharh maqola20223 iqtibosABIPD-1/PD-L1 pathway: current researches in cancer.
Yanyan Han, Dandan Liu, Lianhong Li
Maqola20203 iqtibosABIPrimary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma, Siwen Hu‐Lieskovan, Jennifer A. Wargo +1
Sharh maqola20173 iqtibosABINon-thermal plasma-induced immunogenic cell death in cancer
Marian Khalili, Lynsey Daniels, Abraham Lin +5
Maqola20192 iqtibosABIGeneration and propagation of radical reactions on proteins
Clare L. Hawkins, Michael J. Davies
Sharh maqola20012 iqtibosABIPD-1 and Its Ligands in Tolerance and Immunity
Mary Keir, Manish J. Butte, Gordon J. Freeman +1
Sharh maqola20082 iqtibosABIMolecular Mechanisms of the Efficacy of Cold Atmospheric Pressure Plasma (CAP) in Cancer Treatment
Marie Semmler, Sander Bekeschus, Mirijam Schäfer +12
Sharh maqola20202 iqtibosABILocal and Targeted Delivery of Immune Checkpoint Blockade Therapeutics
Xiao Han, Hongjun Li, Daojia Zhou +2
Maqola20202 iqtibosABITransmembrane domain–driven PD-1 dimers mediate T cell inhibition
Elliot A. Philips, Jia Liu, Audun Kvalvaag +16
Maqola20242 iqtibosABIGlycosylation and Its Role in Immune Checkpoint Proteins: From Molecular Mechanisms to Clinical Implications
Jingyi Liu, Ximo Xu, Hao Zhong +5
Sharh maqola20242 iqtibosABIProteomic Investigation of Immune Checkpoints and Some of Their Inhibitors
Marco Agostini, Pietro Traldi, Mahmoud Hamdan
Sharh maqola20242 iqtibosABI